Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Curacle is a clinical-stage biopharmaceutical company focused on developing treatments for vascular and ophthalmic diseases. Its key pipeline candidates include treatments for endothelial dysfunction and inflammatory bowel disease, among others. It is developing new drugs targeting diseases with high unmet medical needs, such as diabetic macular edema, wet macular degeneration, and diabetic nephropathy.
큐라클은 혈관성 질환 및 안과 질환 치료제 개발에 주력하는 임상 단계 바이오 제약 기업입니다. 주요 파이프라인으로는 혈관내피기능장애 및 염증성 장질환 치료제 등이 있으며, 당뇨병성 황반부종, 습성 황반변성, 당뇨병성 신증 등 미충족 의료 수요가 높은 질환을 대상으로 신약 개발을 진행하고 있습니다.
